Showing 15 posts of 21 posts found.


Baxter partners up with Mayo Clinic for new “centre of exellence” in renal care

October 4, 2018
Research and Development Mayo Clinic, baxter, kidney disease, pharma, renal

American pharma firm Baxter has announced a new partnership with the Mayo Clinic in a bid to establish a “renal …


Baxter hikes 2016 earnings view driven by strong Q1 results

April 27, 2016
Research and Development, Sales and Marketing Baxalta, FY, Q1, baxter, earnings, outlook, results, revenue

Baxter International (NYSE: BAX) reported better-than-expected first-quarter profits and raised its earnings outlook for 2016. The company now sees earnings …


Baxter to cut stake in Baxalta

March 17, 2016
Business Services, Sales and Marketing Baxalta, Shares, Stake sale, baxter

Baxalta Inc (NYSE: BXLT) said former parent company Baxter International (NYSE: BAX) is set to cut its stake in the …


Baxter names José Almeida chairman and chief executive

October 29, 2015
Manufacturing and Production, Research and Development, Sales and Marketing Joe Almeida, José Almeida, baxter

Baxter has named José (Joe) Almeida as the company’s new chairman and chief executive from January 1, 2016. Almeida will …


Baxter recalls saline after mould contamination

October 6, 2015
Manufacturing and Production baxter

Following a number of recalls earlier this year, Baxter has recalled potentially a further 140,000 bags of sodium chloride due …

Shire building

Shire goes public with rejected $30bn Baxalta bid

August 5, 2015
Research and Development, Sales and Marketing Baxalta, Shire, acquisitions, baxter, mergers, rare disease

Shire has confirmed that it made an all-share $30 billion offer to buy Baxalta last month, citing ’a strong strategic …

Baxter buys cancer portfolio for $900 million

May 13, 2015
Research and Development, Sales and Marketing Cancer, Oncaspar, Sigma-Tau Finanziaria, baxter, oncology

Baxter is buying leukaemia treatment Oncaspar from Italian firm Sigma-Tau Finanziaria for $900 million as the US firm looks to …

Manufacturing woes hit Baxter again

April 14, 2015
Manufacturing and Production, Sales and Marketing FDA, Gemünden, Pfizer, alesse, baxter, manufacturing, recall, vectura group

Baxter is voluntarily recalling several lots of intravenous solutions due to the potential presence of particulate matter.  The news has …

Baxter’s haemophilia drug performs

March 17, 2015
Sales and Marketing BAX 817, VIIa, baxter, haemophilia, rFVIIa

Baxter International has reported positive Phase III clinical trial results for its investigational haemophilia drug BAX 817. The recombinant factor VIIa …


Astellas appoints comms head from Baxter

September 18, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Astellas, Burson-Marsteller, Edelman, baxter, christy noland, including GolinHarris

Astellas has hired Christy Noland to be its new director of business communications and advocacy for its urology unit in …


Baxter takes R&D head from Merck Serono

July 15, 2014
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Merck Serono, baxter, john orloff

Baxter International has appointed Dr John Orloff as its vice president and global head of R&D development for Baxter BioScience. …

Baxter to split in two next year

March 28, 2014
Medical Communications, Research and Development, Sales and Marketing AbbVie, Abbott, baxter, biopharma, gambro

Baxter is taking a plunge into the world of restructuring by splitting into two entities: one which is yet to …

Baxter image

Baxter warned by FDA over repeat failings at two plants

June 14, 2013
Manufacturing and Production FDA, baxter

Baxter has attracted the ire of the US Food and Drug Administration over quality failures at two sterile product manufacturing …

Pharma manufacturing news in brief

May 29, 2012
Manufacturing and Production Adienne Pharma & Biotech, Hospira, Neuroptis Biotech, Provence Technologies, Selexis and Florida Biologix, baxter

Hospira overfilled Carpuject cartridges, high-potency certification at Baxter, plus updates from Provence Technologies, Selexis and Florida Biologix. 

Baxter planning $1 billion plasma facility for Atlanta

April 24, 2012
Manufacturing and Production Atlanta, baxter, manufacturing, production

Baxter International has unveiled plans to build a major new manufacturing complex for its plasma-based therapies in Atlanta in the …

Latest content